SCA


Healthy Q2 results; now all eyes on forest valuation review

28/08/19 -"After an extraordinary H2 18, performance normalisation has been picking up momentum in 2019. Yet, despite softening markets, SCA managed to attain an impressive Q2 performance. Continuation of the ..."

Pages
51
Language
English
Published on
28/08/19
You may also be interested by these reports :
23/07/26
Markets have strongly disapproved of UPM’s Q2 results, despite profit metrics coming slightly ahead of street expectations. Pulp (a key strategic ...

23/07/26
Even though Stora’s profit missed street expectations, the results weren’t bad and were similar to Q1 – wherein Packaging remained reassuring. In ...

22/07/26
SCA’s Q2 results were much-better vs. tough Q1 and also marginally exceeded street expectations. While Forest and Energy remained strongholds – with ...

11/05/26
Mayr-Melnhof Karton commenced 2026 on a decent note – evident in Q1 results, which were a beneficiary of optimisation measures. However, the weak end ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO